Purpose: Although collimator rotation is an optimization variable that can be exploited for dosimetric advantages, existing Volumetric Modulated Arc Therapy (VMAT) optimization uses a fixed collimator angle in each arc and only rotates the collimator between arcs. In this study, we develop a novel integrated optimization method for VMAT, accounting for dynamic collimator angles during the arc motion. Methods: Direct Aperture Optimization (DAO) for Dynamic Collimator in VMAT (DC-VMAT) was achieved by adding to the existing dose fidelity objective an anisotropic total variation term for regulating the fluence smoothness, a binary variable for forming simple apertures, and a group sparsity term for controlling collimator rotation. The optimal collimator angle for each beam angle was selected using the Dijkstra's algorithm, where the node costs depend on the estimated fluence map at the current iteration and the edge costs account for the mechanical constraints of multi-leaf collimator (MLC). An alternating optimization strategy was implemented to solve the DAO and collimator angle selection (CAS). Feasibility of DC-VMAT using one full-arc with dynamic collimator rotation was tested on a phantom with two small spherical targets, a brain, a lung and a prostate cancer patient. The plan was compared against a static collimator VMAT (SC-VMAT) plan using three full arcs with 60 degrees of collimator angle separation in patient studies. Results: With the same target coverage, DC-VMAT achieved 20.3% reduction of R50 in the phantom study, and reduced the average max and mean OAR dose by 4.49% and 2.53% of the prescription dose in patient studies, as compared with SC-VMAT. The collimator rotation co-ordinated with the gantry rotation in DC-VMAT plans for deliverability. There were 13 beam angles in the single-arc DC-VMAT plan in patient studies that requires slower gantry rotation to accommodate multiple collimator angles. Conclusions: The novel DC-VMAT approach utilizes the dynamic collimator rotation during arc delivery. In doing so, DC-VMAT affords more sophisticated intensity modulation, alleviating the limitation previously imposed by the square beamlet from the MLC leaf thickness and achieves higher effective modulation resolution. Consequently, DC-VMAT with a single arc manages to achieve superior dosimetry than SC-VMAT with three full arcs.
INTRODUCTION
Volumetric modulated arc therapy (VMAT) is a widely employed radiation therapy treatment technique due to its significantly higher delivery efficiency than conventional static beam intensity modulated radiotherapy (IMRT). 1, 2 Using arcs in treatment planning also reduces the variation in beam orientation selection and simplifies the planning process. The intensity-modulated arc therapy (IMAT) was originally introduced by Yu 3 in 1995, which requires multiple arcs to achieve dosimetry comparable to IMRT. A more practical form of VMAT based on progressive sampling of the gantry angle control points was proposed by Otto. 4 The method was later adopted by many current commercial planning systems.
In the current VMAT implementation, the collimator angle is kept static in each arc, 4 ,5 which we term static collimator VMAT (SC-VMAT) for clarity. The large scale VMAT optimization problem is solved by progressively increasing the beam angle sampling resolution until the full resolution, typically 2 degree separation between beams, is achieved. This progressive sampling approach is computationally straightforward to reach a good balance between optimization speed and plan deliverability, generating deliverable plans that meet mechanical constraints of multi-leaf collimator (MLC). On the other hand, there are several intrinsic limitations with this method. First, the greedy progressive sampling method is heavily influenced by the initial coarse resolution optimization results and can be trapped in an undesirable local minimum solution. Second, the interpolation between adjacent beams can lead to undesired struggles when there is a large change in the target projection shape with gantry rotation. 6 Third, optimization parameter tuning can be tricky as the weightings in different resolution stage of the optimization have a very different impact on the plan quality. Since the plan weightings in various stages of optimization are not easily traceable, exact reproduction of a plan can be difficult, even given the final plan optimization parameters. Last, despite its original promise of single arc optimization, two or more arcs are often used to improve the optimization results. To overcome these limitations, we developed a level-set based direct aperture optimization (DAO) for SC-VMAT. 7 In this approach, the fluence maps of individual beam directions are segmented using its level set function and the entire VMAT optimization problem is efficiently solved in full angular resolution without downsampling. The efficient solution is enabled by a novel hybrid proximal primal dual algorithm. The new single arc VMAT algorithm was shown to outperform the original progressive sampling VMAT method using two arcs. An important motivation of the original two-arc VMAT method is the dosimetric benefit of collimator rotation between arcs. By rotating the collimator, a typically 90°, the MLC moving directions are orthogonal to each other between the two arcs. Although VMAT optimization is performed based on symmetric square beamlets, the two sides of the square are defined differently, by the MLC leaf width and traveling motion respectively, and are effectively asymmetric. The orthogonal arrangement of the two arc VMAT MLC is able to mitigate the asymmetry and improve the dose distribution. 8 However, in this conventional approach, the collimator rotation is used as a user selected constant instead of an optimization parameter that allows greater freedom to choose more than two collimator rotation angles. Studies 9 have shown an improved dose profile using an adjusted collimator angle at each section of the arc in a full-arc VMAT with four sections, as compared with a full-arc SC-VMAT plan. In a heuristic approach to utilize the freedom of collimator rotation within the arc, Zhang et al. 10 developed a collimator trajectory selection paradigm for VMAT in paraspinal SBRT that aligns the collimator angle with the primary cord orientation. This study shows that by simply aligning the collimator with the target shape, a better dose distribution can be achieved. More recently, a beam's-eye-view approach was also proposed to guide the aperture selection for rotational delivery. 11 However, for sites with complex target and OAR sparing requirement, the geometrical approach is inadequate. Instead, a dose domain optimization approach is necessary to select the optimal collimator angle for each gantry angle while still maintaining the mechanical feasibility. In this study, we introduce a novel way of incorporating the dynamic collimator rotation into the single arc nonprogressive sampling VMAT framework for dynamic collimator rotation enabled VMAT (DC-VMAT).
MATERIALS AND METHODS
A flowchart of the proposed DC-VMAT optimization algorithm is shown in Fig. 1 . The optimization alternates between DAO and collimator angle selection (CAS). The DAO includes 3 modules, which solves the DAO optimization problem with respect to the fluence map f ba , the fluence intensity c ba within an aperture, and the aperture variable u ba respectively. Each iteration of the DAO runs through the 3 modules and optimizes one optimization variable, while holding the other two variables constant. This process is repeated until convergence. The CAS is performed on a simplified Dijkstra's map, 12 generated from the result of DAO. The selected collimator angle P ba is translated into the DAO in the next iteration, penalizing unselected candidate beams and encouraging development of the fluence map for selected beams. Formulations of DAO and CAS are presented in Section 2.A, and the corresponding algorithms are discussed in Section 2.B.
2.A. Formulation

2.A.1. Direct aperture optimization
The proposed DC_VMAT DAO formulation takes the following form:
aperture continuity term subject to f ba ! 0; c ba ! 0; 0 u ba 1; b ¼ 1; 2; ::; n b ; a ¼ 1; 2; ::; n a u ¼ ½u
(1) where f ba ; c ba and u ba are the optimization variables. Gantry angles are indexed by b, which ranges from 1 to n b , collimator angles are indexed by a, which ranges from 1 to n a . f ba is the vectorized fluence map of the candidate beam at gantry angle b and collimator angle a. c ba is a scalar quantity and only has one value per gantry angle and collimator angle, which is the fluence intensity that f ba approaches within an aperture. u ba is the aperture variable, defined as 1 where the aperture exists and 0 elsewhere.
The fluence to dose transformation matrix is denoted by A ba , and the desired dose d 0 , is set as the prescription dose at the PTV and zero elsewhere. The weighting matrix W is a diagonal matrix, with weightings for structures of interest as diagonal elements. The derivative matrices, D 1 ba and D 2 ba , take the derivative of the fluence map f ba and aperture u ba in both directions parallel and orthogonal to the MLC leaf movement. P ba is a scalar that equals to 1 for selected on-beams (selected gantry and collimator angle) from collimator angle selection (CAS), and 0 elsewhere. S ba weighs the group sparsity term for each candidate beam to avoid over-penalizing beams with long radiological pathlengths to the target by normalizing based on the A ba matrix. The definition of S ba is
where I PTV is an indicator diagonal matrix for PTV, with its diagonal elements equal to 1 for voxels in PTV and 0 elsewhere, and n ba is the number of beamlets with a trajectory that intersects PTV in beam at gantry angle b and collimator angle a. u is a concatenation of the aperture variables u ba at all gantry angles and collimator angles. The derivative matrix D P takes derivative on the apertures of adjacent selected onbeams.
In Eq.
(1), the data fidelity term minimizes the differences between the calculated dose and the desired dose d. The anisotropic total variation (TV) regularization on fluence map f ba encourages piecewise continuity of the fluence maps within each beam.
13 k 1 and k 2 are hyperparameters controlling the weightings of the TV regularization. A balance between dose fidelity and fluence map continuity improves final dose profile. The single segment term pushes f ba toward c ba where the aperture u ba is 1, and toward 0 where u ba is 0. It encourages fluence map to be a constant within the aperture of each beam, and 0 elsewhere. By weighing this term heavily, the optimizer forces only one aperture segment per beam. The anisotropic TV term on aperture variable u ba encourages intact aperture shape and penalizes holes in the aperture. The group sparsity term is a l 2;1 norm penalty, which promotes group sparsity in the fluence map f ba and inactivates most of candidate beams. Note that this term is controlled by P ba , which only enforces penalty on candidate beams that were not included as on-beams from CAS. The aperture continuity term regulates leaf movement by penalizing differences in apertures between adjacent selected on-beams.
2.A.2. Collimator angle selection
Collimator angle is selected by choosing the shortest path on the simplified Dijkstra's graph. The graph contains n a Ã n b nodes, where each node cost is associated with a candidate beam. The node cost NCðb; aÞ for the candidate beam with gantry angle b and collimator angle a depends on f ba , the fluence map from DAO at the current iteration. The formulation of NCðb; aÞ is given by
Candidate beams that correspond to dose contribution closer to the desired dose distribution will be assigned with lower node costs. By finding the shortest path on the Dijkstra's graph, optimal candidate beams are selected.
The edge costs between every two nodes enforce constraints on trajectory selection. The edge cost between ðb 1 ; a 1 Þ and ðb 2 ; a 2 Þ is defined as
Equation (3) ensures that the collimator angles of adjacent selected on-beams are within collimator rotation speed limits (controlled by a 0 ), and that only one collimator angle is selected per gantry angle. The selected on-beams are denoted by a short , a vector with n b elements, and each element a short ðbÞ represents the selected collimator angle for gantry angle b, ranging from the first gantry angle (b ¼ 1) to the last gantry angle (b ¼ n b ).
Even after regularization using the group sparsity term, there can be multiple collimators angles co-existing in some gantry angles. To allow multiple collimator angles, a few "slow beams" are selected apart from the shortest path a short on the Dijkstra's Map. These slow beams fb 1 ; b 2 ; Á Á Á ; b N g are chosen as the gantry angles that corresponds to the N lowest sum-node-costs, which is defined as
NCðb; aÞ À NCðb; a short ðbÞÞ
When delivering these "slow beams", the gantry slows down to allow a full cycle of collimator rotation. The algorithm that we use to solve the DAO in Eq. (1) cycles among 3 modules, each of which minimizes with respect to one block of variables (either f, c, or u) while holding the other variables constant. Within each module, the optimization problem is solved using an accelerated proximal gradient method known as the Fast Iterative ShrinkageThresholding Algorithm (FISTA).
14,15 FISTA solves optimization problems of the form minimize FðxÞ þ GðxÞ;
(5) where F and G are convex functions, F is differentiable (with a Lipschitz continuous gradient), and G is "simple" in the sense that its proximal operator can be evaluated efficiently. The proximal operator 16 of G is defined by
Note that G is not required to be differentiable. Algorithm 1 shows pseudocode for the FISTA with line search algorithm. The key steps at each iteration of FISTA are to evaluate the gradient of F and the proximal operator of G. For many important convex penalty functions G, explicit formulas for the proximal operator are available.
Algorithm 1. FISTA with line search
The DAO formulation in Eq. (1) was solved using FISTA with respect to the fluence map f ba , the fluence intensity within an aperture c ba , and the aperture variable u ba respectively. Huber penalty 17 was used as a smooth approximation of the l 1 norm to facilitate the application of FISTA, as illustrated in the Appendix B. Details on applying FISTA to each variable are discussed in the Appendices C, D, and E.
2.B.2. Collimator angle selection: Dijkstra's algorithm
Collimator angles are selected by choosing the shortest path on a simplified Dijkstra's graph with n a rows and n b columns,
chosen so that it starts from the first column (b ¼ 1) and ends at the last column (b ¼ n b ), and that only one node is selected per column. Algorithm 2 presents the graph optimization algorithm to find the shortest path a short on the simplified Dijkstra's graph with such layered structure of rows and columns. a short will be a vector with n b elements denoting the selected collimator angle for each gantry angle.
Once a short is chosen, the sum-node-costs is evaluated basing on Eq. (4), and slow beams are selected. P ba is assigned to be 1 for any selected candidate beams, and 0 elsewhere. This variable will be utilized in DAO to discourage the development of any unselected beams. Algorithm 2. Pseudocode for Simplified Dijkstra's algorithm
2.C. Evaluation
The algorithm was first tested on a spherical phantom with a diameter of 10 cm, as shown in Fig. 2 . Two spherical PTVs, with a diameter of 1.3 and 1.7 cm respectively, are distributed symmetrically on the axial plane with a distance of 2.25 cm. The phantom body is the only OAR in this case. The simple geometric configuration provides a controlled test environment for the proposed optimization framework, which focuses on the effects of collimator rotation and rules out other factors that may contribute to the dose outcome, such as the tradeoff among multiple OARs. This phantom is also clinically relevant to multiple brain metastases. The algorithm was also assessed on a glioblastoma multiforme patient (GBM), a lung cancer patient (LNG), and a prostate cancer patient (PRT). Table I shows the respective prescription doses and PTV volumes in all cases.
The dose calculation uses a convolution/superposition code with a 6 MV x ray polyenergetic kernel, described in our previous publications, 18, 19 calculated for 60 gantry angles with 6 degrees of separation and 10 collimator angles with 18 degrees of separation. The ratio of gantry and collimator angular resolution was determined based on relative rotational speed of the collimator and gantry ð x collimator x gantry ¼ 2:5Þ. This ratio can be adjusted based on the actual machine specification.
The dose array resolution was 0.25 9 0.25 9 0.25 cm 3 . For the phantom study, the SC-VMAT plans were generated for both 0.5 9 0.5 cm 2 and 0.25 9 0.25 cm 2 beamlet resolution, and were compared with DC-VMAT plan with 0.5 9 0.5 cm 2 beamlet resolution. In patient cases, the beamlet resolution was 1 9 1 cm 2 due to the limited size of computation.
In the phantom study, both the DC-VMAT and the SC-VMAT plans include one coplanar arc. In patient studies, the DC-VMAT plan results in one coplanar arc with 13 slow beams where the gantry slows down to allow a full collimator rotation, and is compared against SC-VMAT plan with three coplanar arcs with collimator angles at 60°, 120°, 180°, respectively. The SC-VMAT plan utilizes the same optimization model except that collimator angles are fixed within each arc. The travelling time between each beam is 1.2 s, allowing 18°of collimator rotation.
Evaluation includes PTV D95, D98, D99, Dmax, PTV homogeneity, defined as D95 D5 , and the dose conformity, defined as the overlap of the 100% isodose volume and the PTV. For the phantom study, R10-R90 were evaluated to quantitate the dose compactness. For the patient studies, the organs-at-risk (OAR) Dmax and Dmean were assessed. Max dose is defined as the dose at 2% of the structure volume, D2, recommended by the ICRU-83 report.
2.D. Implementation details
To achieve a good balance between dosimetry quality and plan deliverability, there are 8 additional parameters in Eq. (1) that need to be tuned based on the following considerations. k 1 and k 2 were tuned to smooth the fluence map while keeping its major structures. The same principle applied to g 1 ; g 2 ; and g 3 , controlling the smoothness of the aperture variable u ba . c 1 and c 2 are controlled by the equations
where n is the current iteration number and N is the total number of iterations. The monotonically increasing fashion of c 1 and c 2 allows the optimization to focus on the convex dose fidelity term at the early stages of the optimization, and then enforces deliverability during the late iterations. The parameter c 3 is automatically adjusted in optimization to achieve the desired number of on-beam. The parameters used in this study are summarized in Table II. The table gives the initial values of c 1 and c 2 , which monotonically increase following Eq. (6), and c 3 , which is automatically adjusted to achieve the desired number of onbeams. Although the parameter tuning appears to be tedious and empirical, based on our experience, the optimization results are relatively insensitive to these parameters within two orders of magnitude. This is particularly true for patients of the same disease sites where the same set of optimization parameters appear to be adequate without the need for individual tuning.
To accelerate the algorithm, the system matrix A is downsampled in both the fluence map domain and the patient voxel domain. The downsampling in the fluence map domain is performed by removing candidate beams that are inactive throughout the DAO module. In the patient voxel domain, both PTV and OARs are downsampled until collimator angles converge. To avoid geometry deformation of these critical structures through downsampling, we keep a high sampling rate on the outer layer of each structure and a low sampling rate on the interior of each structure. After the collimator angles converge, the DAO is performed with fixed collimator angles and a full sampling of PTV and OARs. 
3.A. Phantom study
With the same target coverage, the DC-VMAT is able to remarkably enhance the dose compactness. Table III shows the comparable PTV statistics of the DC-VMAT plan using 5 mm MLC leaf thickness and the SC-VMAT plan using 5 mm/2.5 mm MLC leaf thickness. Figure 3 shows the percentage reduction in the R10-R90 of the DC-VMAT (5 mm) plan and the SC-VMAT (2.5 mm) plan compared with the SC-VMAT (5 mm) plan. The reduction in dose spillage is remarkably similar between the DC-VMAT (5 mm) plan and the SC-VMAT (2.5 mm) plan, suggesting that the DC-VMAT plan achieves an effectively higher modulation resolution than its physical leaf thickness. Specifically, DC-VMAT (5 mm) plan reduced SC-VMAT (5 mm) plan R50 by 20.3% with the same MLC leaf thickness. The improvement in dose compactness using DC-VMAT (5 mm) and SC-VMAT (2.5 mm) in comparison to SC-VMAT (5 mm) can also be visualized in the isodose line plots (Fig. 4) where the 24, 32, and 40 Gy isodose lines more tightly hug the targets. Figure 5 is a scheme of the fluence map for DC-VMAT plan. Each row corresponds to a collimator angle, at a separation of 18°, and each column represents a gantry angle, at 6°o f separation. The DC-VMAT method optimizes all candidate beams simultaneously and selects the optimal collimator angles for each gantry angle. Thirteen beams are chosen as slow beams, indicated by the columns with all beams on. The maximum allowance of the collimator rotation is 18°between two adjacent beams, as shown in the figure. With the collimator rotation speed limit at 15°/s, the plan takes around 3.5 min in total to deliver. Figure 6 shows the dose distribution of DC-VMAT and SC-VMAT for all patients. By utilizing the new optimization freedom, DC-VMAT was able to achieve better dose sparing on OARs while keeping the same or better PTV coverage. In comparison to SC-VMAT, for the GBM patient, the DC-VMAT was able to reduce dose spillage to the brainstem, chiasm, and right eye, whereas the SC-VMAT covered these OARs with up to 3 Gy of dose. In the LNG case, the DC-VMAT substantially reduced the dose to the ribs near PTV, spinal cord, esophagus and trachea. In the prostate case, DC-VMAT reduced dose to the rectum, R/L Femur, and penile bulb. Figure 7 shows the DVHs of DC-VMAT, SC-VMAT, and clinical VMAT for all patients. The clinical VMAT plan using 5 mm MLC leaf thickness was included as a comparison with the DC-VMAT and SC-VMAT plans using 10 mm MLC leaf thickness. In the GBM case, where the PTV size is comparable to the collimator resolution, the clinical VMAT shows superior dose distribution compared with SC-VMAT, due to larger effect of MLC resolution to a relatively small target. However, DC-VMAT was able to substantially mitigate the MLC resolution disadvantage, and achieve a superior dose distribution to the clinical VMAT plan with twice higher MLC resolution. In the LNG and PRT case, where the difference in MLC resolution is less dominant, both the DC-VMAT and SC-VMAT attained more conformal dose distribution than the clinical VMAT plan, in agreement with our previous study. 7 The PTV statistics of the DC-VMAT plan and SC-VMAT plan were comparable, while the DC-VMAT was able to globally reduce the OAR doses.
3.B. Patient studies
The quantitative statistics for PTV and OARs of the DC-VMAT and SC-VMAT plans are shown in Tables IV and V, respectively. On average, the DC-VMAT plan reduced the OARs max and mean dose by 4.49% and 2.53% of the prescription dose, with the same target coverage. The single largest sparing in OARs max and mean dose is up to 15% and 13.5% of the prescription dose.
DISCUSSION
The nonprogressive-sampling comVMAT model 7 in our previous study optimizes all beams simultaneously instead of progressively inserting new beams, and solves the VMAT optimization problem without relying on greedy heuristics, achieving both theoretical and practical advantages. The DC- VMAT model extends the comVMAT model, and incorporates dynamic collimator rotation during the arc. To incorporate this new freedom, a novel group sparsity term to optimize the collimator/gantry angles and the Dijkstra's term to select the optimal collimator angle for each individual gantry angle were added in the optimization framework. An alternating strategy between the DAO module and the collimator angle selection module was adopted to achieve the final selection of optimal beams. As a result, DC-VMAT is able to achieve a higher effective collimator resolution and subsequently improves dosimetry compared with SC-VMAT, which was shown superior to the existing progressive sampling VMAT method. 7 The superior fluence modulation resolution is particularly demonstrated by the phantom study. Under the controlled condition without tradeoffs among multiple OARs, the improvement in dose compactness using dynamic collimator with standard resolution MLC matched that of the static collimator with high resolution MLC. The improved effective MLC resolution may offer a compelling solution to the difficult decision a radiation oncology department often has to make between MLC leaf resolution and field-of-view.
This current study is different from previous collimator rotation studies 10, 11 in both theory, implementation and results. The previous methods align the collimator angle with organs of distinct geometrical orientations, such as the spinal cord. Because this operation is not included in the optimization, the optimality of such approach cannot be proved. Furthermore, in most clinical cases such as the ones presented in this paper, there is no such clear-cut geometry for the planner to setup collimator angles in the beams-eye-view. Therefore, we believe our method incorporating the collimator rotation term in optimization is more broadly applicable.
An advantage of collimator rotation is that compared to other additional optimization freedoms such as the noncoplanar angles that have been recently researched, collimator rotation is straightforward to implement as it does not increase the risk of collision. For the same reason, there is a potential to safely accelerate collimator rotation for more rapid DC- VMAT delivery. The current collimator rotation speed is limited at 15°/s, and subsequently the estimated delivery time is 72 s for the DC-VMAT one-arc plan and 60 s for the SC-VMAT one-arc plan in the phantom study, and around 200 s for the DC-VMAT one-arc plan with slow beams and 180 s for the three-arc SC-VMAT plan in the patient studies. The delivery time for DC-VMAT could be further reduced with accelerated collimator rotation.
In the patient studies, both the gantry angle and MLC resolution is lower than typical clinical parameters due to two implementation considerations. First, the group sparsity terms on the collimator rotation will penalize similar collimator angles for adjacent beams because they contribute similarly to the dosimetry. This resulted in large collimator rotation between beams. If the gantry angles are more densely sampled, the entire treatment has to slow down to wait for the collimator rotation. The relatively coarse gantry angle gives enough time for the collimator to rotate without having to slow down at most gantry angles. This constraint would be relaxed with aforementioned faster collimator rotation. The second reason is that DC-VMAT is computationally intensive due largely to the size of the optimization problem involving multiple collimator rotations for a gantry angle. Each beamlet of the rotated collimator is considered as an independent candidate. The vast problem size is compounded by the alternating optimization steps between DAO and CAS. To mitigate the computational challenge, the DAO component is now solved using FISTA, a fast proximal gradient method. FISTA is computationally inexpensive, requiring only the multiplication with the system matrix and its transpose at each iteration, instead of solving a linear equation involving the system matrix, which is a typical requirement for other first order methods such as alternating direction method of multipliers (ADMM). 20 FISTA also achieves a convergence rate of Oð 1 k 2 Þ, a significant improvement over the Oð 1 k Þ convergence rate of the other first order methods such as the ADMM and the Chambolle-Pock, 21 which was used in our previous studies for treatment planning optimization. 22, 23 Even with the accelerated algorithm, the DC-VMAT optimization run time varied from 30 min for the GBM case to 3 hr for the LNG case and PRT case, whereas the SC-VMAT optimization run time ranged from 5 min for the GBM case to 30 min for the LNG and PRT case. To further improve the computational performance and use higher MLC resolution, other than moving the calculation from MATLAB to a higher performing language, the optimization may be performed on a parallel computing architecture, where the most computationally expensive matrix multiplication step in FISTA can be parallelized.
Another limitation of this study is that DVH constraints are not used in optimization to maintain convexity in the fidelity term. While DVH constraints can be convenient in clinical practice, introducing them will make the optimization problem more nonconvex, less stable and slower to solve. The current optimization framework was compared with DVH based planning method in Fig. 7 and in our previous study 7 and showed consistently better dosimetric results, proving that the voxel based optimization method is not a major hindrance to achieve high quality plans. The main point of this study is separate from the DVH constraint consideration. We would, of course, investigate the feasibility and implications of adding such terms in future studies.
CONCLUSION
This study presents a novel VMAT method with optimized dynamic collimator rotation (DC-VMAT). The optimization problem was solved by alternating between direct aperture optimization (DAO) and collimator angle selection (CAS) modules and using FISTA and Dijkstra's algorithms, respectively. The results show improved dose compactness and OAR sparing while keeping a similar PTV dosimetry using DC-VMAT, as compared with static collimator VMAT (SC-VMAT) with three coplanar arcs.
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